Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2017

Dec 14, 2017

32227_dirs_2017-12-14_b8254073-5dc2-4cbd-a678-f690a375f22c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-06-27

Reporting Person: JONES STEVEN C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-14 Common Stock G 20000 $9.06 Disposed 226251 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3150000 Indirect
Common Stock 50476 Indirect
Common Stock 52157 Indirect
Common Stock 190000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $4.78 2020-05-04 Common Stock (225000) 225000 Direct
Stock Option (Right to Buy) $7.15 2021-04-20 Common Stock (100000) 100000 Direct
Stock Option $7.27 2022-05-25 Common Stock (10000) 10000 Direct
Restricted Stock $0.00 Common Stock (8667) 8667 Direct

Footnotes

F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.

F5: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F6: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018.

F7: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.